This event in partnership with Manchester Precision Medicine Institute and Health Innovation Manchester will provide attendees with an understanding of precision medicine approaches and an overview of some of the existing research in this area across Manchester and within industry.
Researchers set out to determine whether three of the recommended biologic therapies (etanercept, adalimumab or ustekinumab) for psoriasis elevate the risk of serious infection above that for non-biologic, conventional tablet treatments.
Dermatology researchers are joining scientists from across The University of Manchester at Science Spectacular on Saturday 21 October 2017, for a fun-filled day of challenges, experiments and interactive demonstrations.
The NIHR Manchester BRC, in collaboration with the NIHR Manchester CRF and supported by Oxford Road Corridor and Health Innovation Manchester is investing in the next generation of NHS researchers and want you to be part of it.
This workshop will provide attendees with opportunities to discuss and develop practical strategies for effective PPIE to enhance the design and delivery of their research and to meet the requirements of research funders.
Research recently published in Annals of Rheumatic Diseases has shown genetic markers which differentiate psoriasis and psoriatic arthritis. This important finding will help doctors better understand the mechanism of these conditions and with targeting of future treatment.
The BRC has been busy this summer conducting scoping work to inform an ambitious, five year patient and public involvement and engagement (PPIE) strategy. Delivering exemplary PPIE across Greater Manchester, the strategy will serve both the BRC and the NIHR Manchester CRF.
BRC skin experts Richard Warren and Rachel Watson from the Dermatology Theme have been awarded chairs to mark the academic progress they are leading at The University of Manchester.